THERAPY-RELATED MYELODYSPLASTIC SYNDROME
Clinical trials for THERAPY-RELATED MYELODYSPLASTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new THERAPY-RELATED MYELODYSPLASTIC SYNDROME trials appear
Sign up with your email to follow new studies for THERAPY-RELATED MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune boosting NK cells aim to stop blood cancer relapse after transplant
Disease control Recruiting nowThis study tests whether giving patients their own personalized natural killer (NK) cells after chemotherapy and a cord blood transplant can help kill leftover cancer cells and reduce the risk of graft-versus-host disease. It includes 100 adults with various blood cancers like le…
Matched conditions: THERAPY-RELATED MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New hope for kids with tough blood cancers: drug combo trial launches
Disease control Recruiting nowThis early-stage study tests a drug called venetoclax combined with standard chemotherapy in 30 children, teens, and young adults with high-risk blood cancers like leukemia and myelodysplastic syndrome. The goal is to find the safest dose and understand side effects. Participants…
Matched conditions: THERAPY-RELATED MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: Andrew E. Place, MD • Aim: Disease control
Last updated Jun 03, 2026 13:13 UTC